ABSTRACT
I. Introduction ....................................................................................................53 II. Measurement of Eicosanoids in Exhaled Breath Condensate: Analytical
Methods..........................................................................................................55 A. Isoprostanes ..........................................................................................56 B. Prostanoids............................................................................................57 C. Leukotrienes .........................................................................................57
III. Eicosanoids in Exhaled Breath Condensate in Inflammatory Lung Diseases ..........................................................................................................58 A. Isoprostanes ..........................................................................................58 B. Prostanoids............................................................................................60 C. Leukotrienes .........................................................................................61
IV. Conclusions ....................................................................................................63 Acknowledgment .....................................................................................................63 Further Reading .......................................................................................................63
